AOBIOME
Live / Registered — Registered (as of 18 Mar 2025)
What this means for you
Registered since 18 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97353799
- Registration number
- 7732497
- Mark type
- Stylized text
- Filed
- 08 Apr 2022
- Published for opposition
- 07 Mar 2023
- Registered
- 18 Mar 2025
- Attorney of record
- Ann Lamport Hammitte
Goods and services
- Class 005 — Pharmaceuticals: Medicated gels for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated creams for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated sprays for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; nasal sprays for therapeutic use; topical applications in the nature of gels, creams, sprays, and liquids for therapeutic use, namely, topical preparations containing ammonia oxidizing bacteria for the treatment of skin disorders, acne, inflammation, eye disorders, migraines, headaches, allergic reactions, insomnia, hypertension, thermoregulation, and to promote wound healing; medicated liquids for therapeutic use in the nature of therapeutic pharmaceuticals for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; biological therapeutics being pharmaceutical preparations for treatment of skin disorders, circulatory and cardiovascular disorders, neurologic diseases, inflammation, gastrointestinal disorders, respiratory disorders, eye disorders, urogenital disorders, auditory disorders, migraines, headaches, allergic rhinitis, insomnia, hyperhidrosis, acne, and hypertension; therapeutic agents for thermoregulation and promoting wound healing
Owner
- AOBIOME LLC, Cambridge, MA, US
- AOBIOME LLC, Cambridge, MA, US
- AOBIOME LLC, Cambridge, MA, US
Prosecution history
- 18 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 25 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Jan 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Nov 2024 — USE AMENDMENT FILED
- 17 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Nov 2024 — TEAS STATEMENT OF USE RECEIVED
- 31 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Oct 2024 — SOU EXTENSION 3 GRANTED
- 31 Oct 2024 — SOU EXTENSION 3 FILED
- 31 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 03 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2024 — SOU EXTENSION 2 GRANTED
- 02 May 2024 — SOU EXTENSION 2 FILED